DreamCIS Inc (223250) - Total Liabilities
Based on the latest financial reports, DreamCIS Inc (223250) has total liabilities worth ₩60.03 Billion KRW (≈ $40.68 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
DreamCIS Inc - Total Liabilities Trend (2017–2024)
This chart illustrates how DreamCIS Inc's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of DreamCIS Inc to evaluate short-term liquidity relative to the company's equity base.
DreamCIS Inc Competitors by Total Liabilities
The table below lists competitors of DreamCIS Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Awale Resources Ltd
V:ARIC
|
Canada | CA$1.75 Million |
|
Rent.com.Au Ltd
AU:RNT
|
Australia | AU$6.72 Million |
|
Amiad Water Systems Ltd
TA:AMD
|
Israel | ILA67.43 Million |
|
WASGAU Produktions & Handels AG
F:MSH
|
Germany | €284.84 Million |
|
Viscom AG
XETRA:V6C
|
Germany | €45.49 Million |
|
Top Systems-L
TA:TOPS
|
Israel | ILA234.43 Million |
|
Ji-Haw Industrial Co Ltd
TW:3011
|
Taiwan | NT$1.28 Billion |
|
Samwon Steel
KO:023000
|
Korea | ₩57.80 Billion |
Liability Composition Analysis (2017–2024)
This chart breaks down DreamCIS Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is DreamCIS Inc worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.72 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.39 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how DreamCIS Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for DreamCIS Inc (2017–2024)
The table below shows the annual total liabilities of DreamCIS Inc from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩50.58 Billion ≈ $34.28 Million |
+59.57% |
| 2023-12-31 | ₩31.70 Billion ≈ $21.48 Million |
+9.26% |
| 2022-12-31 | ₩29.01 Billion ≈ $19.66 Million |
+54.92% |
| 2021-12-31 | ₩18.73 Billion ≈ $12.69 Million |
+54.34% |
| 2020-12-31 | ₩12.13 Billion ≈ $8.22 Million |
-14.99% |
| 2019-12-31 | ₩14.27 Billion ≈ $9.67 Million |
+28.92% |
| 2018-12-31 | ₩11.07 Billion ≈ $7.50 Million |
+3.25% |
| 2017-12-31 | ₩10.72 Billion ≈ $7.27 Million |
-- |
About DreamCIS Inc
DreamCIS, Inc. operates as a clinical research organization in South Korea. It offers clinical development services; biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and regulatory consulting services. The company was founded in 2000 and is headqua… Read more